Leucine-rich repeat kinase 2 and alternative splicing in Parkinson's disease

David A Elliott1, Woojin S Kim, Sarsha Gorissen

  • 1Neuroscience Research Australia, Barker St., Randwick, Sydney, NSW 2031, Australia.

Insights

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are linked to Parkinson's disease (PD). This study found LRRK2 influences alternative splicing in neurodegeneration genes, suggesting RNA metabolism alterations contribute to PD.

Area of Science:

  • Neuroscience
  • Genetics
  • Molecular Biology

Background:

  • Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most common genetic cause of Parkinson's disease (PD).
  • LRRK2 mutations are associated with diverse neuropathological findings.
  • The precise mechanisms by which LRRK2 mutations contribute to PD pathogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the hypothesis that LRRK2 mediates its pathogenic effects through alternative splicing of neurodegeneration-associated genes.
  • To explore the role of LRRK2 in regulating gene expression and RNA splicing patterns relevant to Parkinson's disease.

Main Methods:

  • Western blotting to analyze subcellular protein fractions.
  • Exon-array analysis of RNA from neuroblastoma cells transfected with LRRK2 expression vectors.
  • Reverse-transcription polymerase chain reaction (RT-PCR) on cultured cells and postmortem Parkinson's disease brain tissue.

Main Results:

  • Overexpression of LRRK2 (G2019S mutant) significantly decreased nuclear transactive response DNA-binding protein 43 (TRDDPB) levels.
  • LRRK2 significantly affected the expression of genes involved in nuclear functions and cell-cycle regulation.
  • Altered splicing of microtubule-associated protein tau (MAPT) and alpha-synuclein (SNCA) genes was observed upon LRRK2 overexpression, and in postmortem PD brains.

Conclusions:

  • Aberrant RNA metabolism, specifically altered alternative splicing, is implicated as a significant contributor to idiopathic Parkinson's disease.
  • LRRK2 plays a role in regulating RNA splicing of key genes associated with neurodegeneration.
  • These findings highlight potential therapeutic targets within RNA processing pathways for Parkinson's disease treatment.

Related Concept Videos

Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.